H. Itoh et al. / Tetrahedron: Asymmetry 27 (2016) 698–705
703
4.2. General procedure of citronellal analogues ( )-1, ( )-3, ( )-5
and ( )-7 kinetic resolution by a ring-closing ene reaction
catalyzed by (R)-BINOL-Al
(minor); 13C NMR (125 MHz, CDCl3): 19.9 (CH3), 27.8 (CH2), 31.3
(CH3), 37.1 (CH2), 38.8 (C), 40.6 (CH2), 50.2 (CH), 55.9 (CH3), 74.9
(CH), 84.8 (C), 112.2 (CH2), 113.5 (CH2), 121.5 (C), 123.8 (C),
126.1 (C), 127.5 (CH), 128.2 (CH), 128.7 (CH), 129.4 (CH), 129.7
(CH), 144.8 (CH), 146.1 (C) (major); 13C NMR (125 MHz, CDCl3):
22.2 (CH3), 27.1 (CH2), 31.3 (CH3), 35.8 (CH2), 37.8 (C), 41.1
(CH2), 50.5 (CH), 55.4 (CH3), 74.7 (CH), 85.0 (C), 112.5 (CH2),
113.5 (CH2), 121.5 (C), 123.8 (C), 127.5 (C), 127.5 (CH), 128.2
(CH), 128.7 (CH), 129.4 (CH), 129.7 (CH), 145.9 (C), 148.9 (CH)
(minor).
A mixture of (R)-BINOL (R)-L1a (57.2 mg, 0.200 mmol, 5 mol %,
1.8 equiv vs Al), triethylaluminium 1.0 mol/L toluene solution
(0.11 mL, 0.110 mmol, 5 mol %), and toluene (1.2 mL) as added to
a 50-mL Schlenk tube under an N2 atmosphere. After being stirred
at rt for over 1 h, the solution was cooled to less than 10 °C. The
citronellal analogue (2.22 mmol) was added dropwise slowly
under 10 °C and stirred for a given amount of time. Samples of
the solution were consecutively taken at given time periods and
analyzed by GC. The citronellal analogues in the reaction mixture
were collected by silica-gel column chromatography or preparative
TLC separation (heptane/AcOEt = 7/1) with 2,6-diphenylphenol
and reacted by Al-MCM-41 (cat. amount) in toluene at 80 °C in
order to analyze their enantioselectivity.23 The authentic samples
of racemic 2, 4, 6 and 8 were also prepared by cyclization catalyzed
by Al-MCM-41.
4.6. (R)-(5-Methyl-2-(prop-1-en-2-yl)-5-vinylcyclohexyl)3,3,3-
trifluoro-2-methoxy-2-phenylpropanoate (1R,2S,5S/1R,2S,5R =
68/32) ((R)-MTPA ester of (+)-2)17
1H NMR (500 MHz, CDCl3): d 1.03 (3H, s), 1.23–1.51 (3H, m),
1.53 (3H, br), 1.55–1.72 (2H, m), 2.10–2.14 (1H, m), 2.19–2.24
(1H, m), 3.57 (3H, s), 4.58–4.84 (3H, m), 4.96 (1H, dd, J 17.5,
1.0 Hz), 5.16 (1H, dd, J 10.9, 0.8 Hz), 5.18–5.27 (1H, m), 7.35–7.60
(5H, m) (major); 1H NMR (500 MHz, CDCl3): d 1.14 (3H, s), 1.21–
1.71 (4H, m), 1.60 (3H, br), 1.87–1.93 (1H, m), 2.19–2.27 (2H, m),
3.52 (3H, s), 4.77–4.86 (3H, m), 4.91 (1H, dd, J 10.7, 1.0 Hz),
5.22–53.4 (2H, m), 7.35–7.60 (5H, m) (minor); 13C NMR
(125 MHz, CDCl3): 19.9 (CH3), 27.3 (CH2), 30.5 (CH3), 37.1 (CH2),
38.4 (C), 40.6 (CH2), 50.2 (CH), 55.9 (CH3), 74.9 (CH), 84.8 (C),
112.2 (CH2), 113.5 (CH2), 121.5 (C), 123.8 (C), 126.1 (C), 127.5
(CH), 128.2 (CH), 128.7 (CH), 129.4 (CH), 129.7 (CH), 144.8 (CH),
146.1 (C) (major); 13C NMR (125 MHz, CDCl3): 22.2 (CH3), 27.3
(CH2), 30.5 (CH3), 35.8 (CH2), 37.3 (C), 41.1 (CH2), 50.5 (CH), 55.4
(CH3), 74.7 (CH), 85.0 (C), 112.5 (CH2), 113.5 (CH2), 121.5 (C),
123.8 (C), 127.5 (C), 127.5 (CH), 128.2 (CH), 128.7 (CH), 129.4
(CH), 129.7 (CH), 145.9 (C), 148.9 (CH) (minor).
4.3. (R)-(ꢀ)-3-Vinyl-3,7-dimethyloct-6-enal ((R)-(ꢀ)-3-vinylcit-
ronellal) (ꢀ)-1 (Table 1, entry 1)
Obtained as a yellowish oil. Yield 152 mg from 400 mg of ( )-1
(38%). [
a]
20 = ꢀ14.1 (c 0.08, EtOH, 25% ee); 1H NMR (500 MHz,
D
CDCl3): d 1.16 (3H, s), 1.39–1.47 (2H, m), 1.58 (3H, s), 1.67 (3H,
s), 1.92 (2H, q, J 8.3 Hz), 2.34 (2H, qd, J 14.9, 2.8 Hz), 5.02 (1H, d,
J 17.6 Hz), 5.03–5.9 (1H, m), 5.11(1H, d, J 10.8 Hz), 5.85 (1H, dd, J
17.6, 10.9 Hz), 9.73 (1H, t, 2.8 Hz); 13C NMR (125 MHz, CDCl3):
17.6 (CH3), 22.6 (CH2), 23.4 (CH3), 25.6 (CH3), 39.0 (C), 41.4
(CH2), 53.1 (CH2), 113.2 (CH2), 124.0 (CH), 131.8 (C), 145.0 (CH),
203.3 (CHO); HRMS (FI): M+, found 180.1502. C12H20O requires
180.1514.
4.7. (S)-(+)-3-Vinyl-3,7-dimethyloct-6-enal ((S)-(+)-3-vinylcitro-
4.4. (+)-5-Vinyl-5-methyl-2-(prop-1-en-2-yl)cyclohexanol ((+)-
5-vinylisopulegol) (+)-2 (1R,2S,5S/1R,2S,5R = 68/32) (absolute
stereochemistry) (Table 1, entry 1)
nellal) (+)-1 (Table 1, entry 2)
Obtained as a yellow oil. Yield 48 mg at 81% conversion from
400 mg of ( )-1 (12%). [a]
20 = +11.6 (c 0.08, EtOH, 30% ee); 1H
D
Obtained as a colorless oil. Yield 189 mg from 400 mg of ( )-1
NMR (500 MHz, CDCl3): d 1.15 (3H, s), 1.39–1.45 (2H, m), 1.57
(3H, s), 1.67 (3H, s), 1.89–1.94 (2H, m), 2.29–2.40 (2H, m), 5.00
(1H, d, J 17.6 Hz), 5.03–5.9 (1H, m), 5.12(1H, d, J 10.8 Hz), 5.82
(1H, dd, J 17.5, 10.9 Hz), 9.72 (1H, t, 2.8 Hz); 13C NMR (125 MHz,
CDCl3): 17.5 (CH3), 22.5 (CH2), 23.4 (CH3), 25.6 (CH3), 38.9 (C),
41.3 (CH2), 53.0 (CH2), 113.1 (CH2), 124.0 (CH), 131.7 (C), 145.0
(47%). [a]
20 = +9.7 (c 0.11, EtOH, 71% ee (anti-2), 89%ee (syn-2));
D
1H NMR (500 MHz, CDCl3): d 1.01 (3H, s), 1.20–1.34 (3H, m),
1.42–1.65 (4H, m), 1.69 (3H, s), 1.70–1.80 (1H, m), 1.87–1.92
(1H, m), 2.10 (1H, ddd, J 12.9, 3.7, 2.6 Hz), 4.84–5.07 (3H, m),
5.75 (1H, dd, J 17.7, 11.0 Hz) (major); 1H NMR (500 MHz, CDCl3):
d 1.05 (3H, s), 1.20–1.65 (8H, m), 1.75 (3H, s), 1.82–1.92 (2H, m),
4.84–5.07 (3H, m), 5.82 (1H, dd, J 17.5, 1.8 Hz) (minor); 13C NMR
(125 MHz, CDCl3): 19.2 (CH3), 26.4 (CH), 31.5 (CH3), 36.9 (CH2),
38.9 (C), 44.8 (CH2), 54.7 (CH), 67.3 (CH), 112.4 (CH2), 112.9
(CH2), 145.9 (CH), 146.6 (C) (major); 13C NMR (125 MHz, CDCl3):
19.3 (CH3), 22.7 (CH3), 25.9 (CH2), 36.1 (CH2), 37.8 (C), 43.9
(CH2), 54.7 (CH), 67.4 (CH), 109.4 (CH2), 112.9 (CH2), 146.4 (C),
(CH), 203.2 (CHO); HRMS (FI): M+, found 180.1513. C12H20
requires 180.1514.
O
4.8. (ꢀ)-5-Vinyl-5-methyl-2-(prop-1-en-2-yl)cyclohexanol ((ꢀ)-
5-vinylisopulegol) (ꢀ)-2 (1S,2R,5R/1S,2R,5S = 66/34) (absolute
stereochemistry) (Table 1, entry 2)
149.9 (CH) (minor); HRMS (FI): M+, found 182.1676. C12H20
requires 182.1671 (mixture).
O
Obtained as a colorless oil. Yield 195 mg at 81% conversion from
400 mg of ( )-1 (49%). [
a
]
20 = ꢀ8.8 (c 0.03, EtOH, 60% ee (anti-2),
D
91%ee (syn-2)); 1H NMR (500 MHz, CDCl3): d 1.02 (3H, s), 1.20–
1.34 (3H, m), 1.42–1.65 (4H, m), 1.69 (3H, s), 1.70–1.80 (1H, m),
1.87–1.92 (1H, m), 2.10 (1H, ddd, J 12.9, 3.7, 2.6 Hz), 4.83–5.08
4.5. (S)-(5-Methyl-2-(prop-1-en-2-yl)-5-vinylcyclohexyl)3,3,3-
trifluoro-2-methoxy-2-phenylpropanoate (1R,2S,5S/1R,2S,5R =
68/32) ((S)-MTPA ester of (+)-2)17
(3H, m), 5.75 (1H, dd,
J
17.7, 11.1 Hz) (major); 1H NMR
(500 MHz, CDCl3): d 1.05 (3H, s), 1.20–1.65 (8H, m), 1.75 (3H, s),
1.82–1.92 (2H, m), 4.83–5.08 (3H, m), 5.82 (1H, dd, J 17.5, 1.8 Hz)
(minor); 13C NMR (125 MHz, CDCl3): 19.2 (CH3), 26.4 (CH), 31.5
(CH3), 36.9 (CH2), 38.9 (C), 44.8 (CH2), 54.7 (CH), 67.3 (CH), 112.5
(CH2), 112.9 (CH2), 145.9 (CH), 146.6 (C) (major); 13C NMR
(125 MHz, CDCl3): 19.3 (CH3), 22.7 (CH3), 25.9 (CH2), 36.1 (CH2),
37.8 (C), 43.9 (CH2), 54.7 (CH), 67.4 (CH), 109.4 (CH2), 112.9
(CH2), 146.4 (C), 149.9 (CH) (minor); HRMS (FI): M+, found
182.1676. C12H20O requires 180.1514 (mixture).
1H NMR (500 MHz, CDCl3): d 1.00 (3H, s), 1.21–1.60 (4H, m),
1.66 (3H, t, J 0.9 Hz), 2.12–2.22 (3H, m), 3.52 (3H, d, J 1.1 Hz),
4.77–4.86 (3H, m), 4.92 (1H, dd, J 15.7, 1.0 Hz), 5.16 (1H, dd, J
10.9, 0.9 Hz), 5.18–5.27 (1H, m), 7.35–7.60 (5H, m) (major); 1H
NMR (500 MHz, CDCl3): d 1.16 (3H, s), 1.21–1.71 (4H, m), 1.73
(3H, t, J 0.9 Hz), 1.81–1.87 (1H, m), 2.15–2.28 (2H, m), 3.56 (3H,
d, J 1.3 Hz), 4.77–4.86 (3H, m), 4.90 (1H, dd, J 8.0, 1.0 Hz), 5.25
(1H, dd, J 17.8, 0.8 Hz), 5.27–5.34 (1H, m), 7.35–7.60 (5H, m)